Managing Partner at Qiming Venture Partners
Member of RISE Conference Alumni 2019
This profile is maintained by the Onstage curation team using publicly available information. If this is your profile, claim it!Claim profile
Nisa Leung is a Managing Partner of Qiming Venture Partners, leading its health care investments.
Prior to joining Qiming, she was co-founder of Biomedic Holdings with operations and investments in medical devices, pharmaceuticals and health care services in China including Novamed Pharmaceuticals (acquired by SciClone) and U-Systems (acquired by GE Healthcare). Nisa was Venture Partner of PacRim Ventures in Menlo Park, and was previously with Softbank/Mobius Venture Capital.
Nisa currently sits on the board of Gan & Lee Pharmaceutical, Zai Lab (NASDAQ:ZLAB), Nurotron, Venus Medtech, Goodwill Infotech, dMed, CanSino biotechnology, New horizon Bio and Berry Oncology. Nisa other investments include Acea biosciences, Berry genomics (SZSE: 000710),CITIC Pharmaceuticals (acquired by Shanghai Pharmaceuticals), OriGene Technologies (acquired by VCAN Bio), Shenogen, Crown Bioscience (GTSM: 6554), Novast pharma, Aeonmed, Wuxi Leiming, Richen, Chain Medical Labs, Suzhou qiagen, Cure Genetics and Jacobio.